Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology-Reference-Cited by-同舟云学术

Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Published:2022-02 Issue:1 Volume:44 Page:121-132
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Reuter Stephanie E.,Stocker Sophie L.,Alffenaar Jan-Willem C.,Baldelli Sara,Cattaneo Dario,Jones Graham,Koch Birgit C. P.,Kocic Danijela,Mathew Sumith K.,Molinaro Mariadelfina,Neely Michael,Sandaradura Indy,Marriott Deborah J. E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference91 articles.

1. Vancomycin trough concentration as a predictor of clinical outcomes in patients with Staphylococcus aureus bacteremia: a meta-analysis of observational studies;Prybylski;Pharmacotherapy,2015

2. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing;Tsutsuura;BMC Infect Dis,2021

3. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists;Rybak;Am J Health Syst Pharm,2020

4. Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations;Colin;Clin Pharmacokinet,2019

5. The therapeutic monitoring of antimicrobial agents;Begg;Br J Clin Pharmacol,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated calculation and reporting of vancomycin area under the concentration–time curve: a simplified single-trough concentration-based equation approach;Antimicrobial Agents and Chemotherapy;2024-08-28

2. Evaluation of target area under the concentration–time curve of vancomycin in an initial dosing design: a retrospective cohort study;Journal of Antimicrobial Chemotherapy;2024-07-19

3. Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China;Frontiers in Pharmacology;2024-07-12

4. Effects of lung inflammation and injury on pulmonary tissue penetration of meropenem and vancomycin in a model of unilateral lung injury;International Journal of Antimicrobial Agents;2024-07

5. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients;Pharmacology Research & Perspectives;2024-06-28